NCT06409962 A New Technological Intervention to Address Childhood Obesity:
| NCT ID | NCT06409962 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad de Córdoba |
| Condition | Body Weight |
| Study Type | INTERVENTIONAL |
| Enrollment | 215 participants |
| Start Date | 2024-05-30 |
| Primary Completion | 2026-12-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 215 participants in total. It began in 2024-05-30 with a primary completion date of 2026-12-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Childhood obesity is a global public health issue, with rising prevalence rates. In Spain, the problem is significant, particularly in the southern regions. Factors contributing to childhood obesity include dietary habits, lack of physical activity, and socioeconomic influences. Efforts to address childhood obesity in Spain include various programs focusing on dietary modification, increased physical activity, and family involvement. Despite these initiatives, there is a need for continued intervention, as changing dietary and lifestyle patterns have led to reduced fruit and vegetable consumption and increased sedentary behavior among children. Childhood obesity has concerning health implications, including heart-related issues. Echocardiography plays a vital role in early detection. Given the limited research on the impact of childhood obesity on musculoskeletal development and mobility, a comprehensive study is needed to analyze its prevalence and associated factors. The study aims to assess the effectiveness of nutritional interventions administered by school nurses. In summary, childhood obesity in Spain is a growing concern, with multifaceted causes and health implications. Ongoing efforts are required to combat this issue and promote healthier lifestyles among children.
Eligibility Criteria
Inclusion Criteria: * Students from the school * Pediatric from age 6 to 16 * Students from the school that confirmed approval * Signed informed consent by the minor * Signed informed consent by the minor's parents or guardians. Exclusion Criteria: * Presence of HbA1c levels below 5.7% * Presence of HbA1c levels above 6.4% * Presence of pathological metabolic diseases, such as diabetes or metabolic syndrome * Presence of other diseases related to intestinal integrity or skin issues. * Lack of the signed informed consent by the minor and legal guardian
Contact & Investigator
Manuel Vaquero Abellan, MD, Msc, PhD
STUDY DIRECTOR
Universidad de Córdoba
Frequently Asked Questions
Who can join the NCT06409962 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 16 Years, studying Body Weight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06409962 currently recruiting?
Yes, NCT06409962 is actively recruiting participants. Contact the research team at jefaturadeprimaria@colegiovirgendelcarmen.com for enrollment information.
Where is the NCT06409962 trial being conducted?
This trial is being conducted at Córdoba, Spain.
Who is sponsoring the NCT06409962 clinical trial?
NCT06409962 is sponsored by Universidad de Córdoba. The principal investigator is Manuel Vaquero Abellan, MD, Msc, PhD at Universidad de Córdoba. The trial plans to enroll 215 participants.